Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine: a randomized trial in 10-25-year-old HIV-Seronegative African girls and young women. (2013)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/infdis/jis619

PubMed Identifier: 23242542

Publication URI: http://europepmc.org/abstract/MED/23242542

Type: Journal Article/Review

Volume: 207

Parent Publication: The Journal of infectious diseases

Issue: 11

ISSN: 0022-1899